ADM knockdown inhibited, whereas miR-1297 inhibition promoted glioma cell viability; ADM knockdown partially attenuated miR-1297 inhibition effects on cell viability (Fig. 6B). The gene discussed is ADM; the disease is central nervous system cancer.